On TravelingCrossing
Employment News
King Pharmaceuticals is cutting 760 jobs, or 22% of its workforce.
About 240 of the job losses are corporate positions associated with King’s $1.6 billion acquisition of drugmaker Alpharma. Of the rest, about 380 are in sales and about 140 are corporate.
The restructuring leaves King, which makes the blood pressure drug Altace, with a branded product sales force of about 720.
The Bristol, Tennessee-based company said the restructuring was sparked in part by a recent federal court decision invalidating two patents related to the company’s muscle relaxant Skelaxin.
Only TravelingCrossing consolidates every job it can find in the domain and puts all of the job listings it locates in one place.